Free Trial
OTCMKTS:LXRP

Lexaria Bioscience (LXRP) Stock Price, News & Analysis

Lexaria Bioscience logo

About Lexaria Bioscience Stock (OTCMKTS:LXRP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.15 million shs
Average Volume
608,350 shs
Market Capitalization
$20.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

Receive LXRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

LXRP Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
LEXX: Second Quarter Results
See More Headlines

LXRP Stock Analysis - Frequently Asked Questions

Shares of LXRP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lexaria Bioscience investors own include Canopy Growth (CGC), Organigram (OGI), Walt Disney (DIS), Aurora Cannabis (ACBFF), Alibaba Group (BABA), Tilray (TLRY) and NVIDIA (NVDA).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Metal Mining
Sub-Industry
N/A
Current Symbol
OTCMKTS:LXRP
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,090,000.00
Net Margins
-1,046.77%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$380,000.00
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$20.15 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:LXRP) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners